MEP Stock Overview
Mediclinic International plc, together with its subsidiaries, operates private hospitals.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Mediclinic International plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£118.30 |
52 Week High | UK£119.45 |
52 Week Low | UK£76.39 |
Beta | 0.42 |
1 Month Change | 3.19% |
3 Month Change | 9.33% |
1 Year Change | 52.31% |
3 Year Change | 84.38% |
5 Year Change | 18.76% |
Change since IPO | -40.40% |
Recent News & Updates
Recent updates
Shareholder Returns
MEP | NA Healthcare | NA Market | |
---|---|---|---|
7D | 0.3% | 0% | 0% |
1Y | 52.3% | 0% | 0% |
Return vs Industry: MEP exceeded the NA Healthcare industry which returned 4.3% over the past year.
Return vs Market: MEP exceeded the NA Market which returned 19.3% over the past year.
Price Volatility
MEP volatility | |
---|---|
MEP Average Weekly Movement | 2.1% |
Healthcare Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in NA Market | 0% |
10% least volatile stocks in NA Market | 0% |
Stable Share Price: MEP has not had significant price volatility in the past 3 months.
Volatility Over Time: MEP's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | 33,683 | Ronnie van der Merwe | www.mediclinic.com |
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom.
Mediclinic International plc Fundamentals Summary
MEP fundamental statistics | |
---|---|
Market cap | R90.23b |
Earnings (TTM) | R4.13b |
Revenue (TTM) | R82.64b |
21.9x
P/E Ratio1.1x
P/S RatioIs MEP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MEP income statement (TTM) | |
---|---|
Revenue | UK£3.38b |
Cost of Revenue | UK£2.66b |
Gross Profit | UK£728.00m |
Other Expenses | UK£559.00m |
Earnings | UK£169.00m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.23 |
Gross Margin | 21.52% |
Net Profit Margin | 5.00% |
Debt/Equity Ratio | 54.1% |
How did MEP perform over the long term?
See historical performance and comparison